For Halloween, BioSpace collected six tales of thrills and chills from the pharma and biotech industries that will surely have you covering your eyes in terror.

Bavarian Nordic became the first company to win approval for the only vaccine designed to prevent smallpox and monkeypox disease in adults who are considered at high risk of the viruses.

Aradigm Corp.’s inhaled antibiotic for a rare, incurable disorder affecting the lungs failed a late-stage study, sending the company’s shares down in premarket trading.

The U.S. Department of Health and Human Services (HHS) said on Wednesday it signed a deal with British drugmaker AstraZeneca Plc to develop antibiotics. The federal agency said it will share costs with AstraZeneca to develop a portfolio of drugs to treat illnesses caused by bioterrorism agents and antibiotic-resistant infections. The Biomedical Advanced Research and […]